1. Cisplatin combination drugs induce autophagy in HeLa cells and interact with HSA via electrostatic binding affinity
   Xuerui Chen et al, 2017, RSC Adv. CrossRef
2. The roles of subcellularly located EGFR in autophagy
   Hongsen Li et al, 2017, Cellular Signalling CrossRef
3. Knockdown of STMN1 enhances osteosarcoma cell chemosensitivity through inhibition of autophagy
   Zili Wang et al, 2017 CrossRef
4. Regorafenib induces lethal autophagy arrest by stabilizing PSAT1 in glioblastoma
   Jingwen Jiang et al, 2019, Autophagy CrossRef
5. Molecular Mechanisms Underlying Autophagy-Mediated Treatment Resistance in Cancer
   Cally J. Ho et al, 2019, Cancers CrossRef
6. Insight Into the Role of Autophagy in Osteosarcoma and Its Therapeutic Implication.
   Jianfang Niu et al, 2019, Front Oncol CrossRef
7. The role of Caspase-1/GSDMD-mediated pyroptosis in Taxol-induced cell death and a Taxol-resistant phenotype in nasopharyngeal carcinoma regulated by autophagy.
   Xianyao Wang et al, 2020, Cell Biol Toxicol CrossRef
8. Combination of an Autophagy Inducer and an Autophagy Inhibitor: A Smarter Strategy Emerging in Cancer Therapy.
   Ting Liu et al, 2020, Front Pharmacol CrossRef
9. Targeting autophagy is a promising therapeutic strategy to overcome chemoresistance and reduce metastasis in osteosarcoma
   Yu‑Xin Liao et al, 2019, Int J Oncol CrossRef
10. Combination of pristimerin and paclitaxel additively induces autophagy in human breast cancer cells via ERK1/2 regulation
    Younju Lee et al, 2018, Mol Med Report CrossRef
11. New Advances in the Research of Resistance to Neoadjuvant Chemotherapy in Breast Cancer
    Junsha An et al, 2021, IJMS CrossRef
12. Role of autophagy in drug resistance and regulation of osteosarcoma (Review)
    Yanchuan Pu et al, 2022, Mol Clin Oncol CrossRef
13. Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality
    Lei Yu et al, 2022, Front. Immunol. CrossRef
14. Superenhancers activate the autophagy-related genes Beclin1 and LC3B to drive metastasis and drug resistance in osteosarcoma
    Hongyi Wang et al, 2022, Front. Med. CrossRef
15. Hypoxia inducible factor-1ɑ as a potential therapeutic target for osteosarcoma metastasis
    Jianghu Zhou et al, 2024, Front. Pharmacol. CrossRef